Heartburn: all 154 studies
Page 1 of 2. Open to participants first (12), then studies with results posted, then the rest; newest registration first within each.
- A Clinical Trial to Evaluate the Effects of a Supplement on Gut HealthRecruitingNCT07927907Not applicable
- Vinegar and HeartburnRecruitingNCT07927296Not applicable
- Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux SymptomsEnrolling by invitationNCT07707011Not applicable
- Volume-Oriented Incentive Spirometry-Assisted Diaphragmatic Breathing Exercise for Functional Heartburn or Reflux HypersensitivityNot yet recruitingNCT07706101Not applicable
- Antireflux Surgery Without Preoperative Esophageal ManometryNot yet recruitingNCT07659080Not applicable
- New Topical tReatment Options for Symptomatic patiEnts With Nonerosive gastroesophageaL Reflux dIsease (The RELIEF Trial)RecruitingNCT07624383Not applicable
- Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI TherapyRecruitingNCT07291700
- A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their OffspringRecruitingNCT06660342
- Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy VolunteersRecruitingNCT06098742Not applicable
- A Study of Breath Testing for Small Intestinal Bacterial OvergrowthRecruitingNCT05976165Not applicable
- Prevalence of Fuctional Heartburn in Patients With IBS .Not yet recruitingNCT05901740
- Prevalence of Mast Cell Activation Syndrome in Patients With EDS With Digestive DisordersRecruitingNCT05382169
- A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice DailyCompletedNCT06391177Phase 1Results posted
- Trial of Itopride 150mg Once a Day Versus Itopride 50 mg Thrice a Day; in Patients With Functional DyspepsiaCompletedNCT06217393Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)CompletedNCT05195528Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux DiseaseCompletedNCT04799158Phase 2Results posted
- Remote Guided Caffeine ReductionCompletedNCT04560595Not applicableResults posted
- Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese PatientsCompletedNCT02873689Phase 3Results posted
- Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor TreatmentCompletedNCT02708355Phase 4Results posted
- Symptom Control Satisfaction With Proton Pump Inhibitor RegimenCompletedNCT02623816Phase 4Results posted
- The CALIBER Study Randomized Controlled Trial of LINX Versus Double-Dose Proton Pump Inhibitor Therapy for Reflux DiseaseCompletedNCT02505945Phase 4Results posted
- Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating TabletsCompletedNCT02096458Phase 1Results posted
- Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard EndoscopyCompletedNCT02066233Not applicableResults posted
- Response to Supplement and Placebo in GERDCompletedNCT01915173Not applicableResults posted
- Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERDCompletedNCT01882088Phase 4Results posted
- Compound Sodium Alginate Double Action Chewable Tablet Symptomatic Relief StudyCompletedNCT01869491Phase 3Results posted
- The EndoGastric Solutions TEMPO TrialCompletedNCT01647958Not applicableResults posted
- Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)CompletedNCT01587885Phase 4Results posted
- To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving RabeprazoleCompletedNCT01397084Phase 4Results posted
- Efficacy of Esomeprazole in Patients With Frequent HeartburnCompletedNCT01370538Phase 3Results posted
- Efficacy of Esomeprazole in Patients With Frequent HeartburnCompletedNCT01370525Phase 3Results posted
- Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF StudyTerminatedNCT01327963Not applicableResults posted
- To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving RabeprazoleCompletedNCT01249651Phase 4Results posted
- Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of HeartburnCompletedNCT01037452Phase 2Results posted
- Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPICompletedNCT01005251Phase 2Results posted
- A Study to Assess the Bioequivalence of Famotidine Chewable Tablets and Film-Coated Tablets (0208-144)CompletedNCT00945750Phase 1Results posted
- A Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets Compared to Famotidine/Antacid EZ Chew Tablets (0208C-145)(COMPLETED)CompletedNCT00944671Phase 1Results posted
- Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyCompletedNCT00847808Phase 3Results posted
- Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux DiseaseCompletedNCT00847210Phase 1Results posted
- A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)CompletedNCT00734097Phase 4Results posted
- Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) SymptomsCompletedNCT00703534Phase 2Results posted
- An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe DiseaseCompletedNCT00701129Phase 4Results posted
- A Study of Dexlansoprazole Modified Release Formulation to Treat Night HeartburnCompletedNCT00627016Phase 3Results posted
- Role of Pain Modulation in GERD Patients Who Failed Standard Dose PPICompletedNCT00539240Phase 2/3Results posted
- Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in GastroparesisCompletedNCT00492622Phase 4Results posted
- A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mgCompletedNCT00464308Phase 4Results posted
- Symptom Improvements in Gastroesophageal Reflux Disease (GERD) PatientsCompletedNCT00394472Phase 2Results posted
- Safety and Efficacy Study of Axid Use in Infants Suffering From Gastroesophageal Reflux Disease (GERD)CompletedNCT00373334Phase 3Results posted
- Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux DiseaseCompletedNCT00321984Phase 3Results posted
- Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat HeartburnCompletedNCT00251745Phase 3Results posted
- E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent SufferersCompletedNCT00236197Phase 3Results posted
- E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent SufferersCompletedNCT00236184Phase 3Results posted
- A Pre-market, Two-stages Interventional Clinical Investigation to Evaluate the Safety and the Performance of Fibroin Syrup in Reducing the Gastroesophageal Reflux Disease (GERD) Symptomatology in Nonerosive Reflux Disease (NERD) PatientsCompletedNCT07563790Not applicable
- A Clinical Trial of PepZinGI® for Acute Heartburn Relief and Sleep OutcomesCompletedNCT07379645Not applicable
- Observationa Study is a Prospective and Multi-institutional Observational Study.CompletedNCT06952855
- The Anti-gastroesophageal Reflux Effect of Anvitra Gastric Suspension on Outpatients With Gastroesophageal Reflux DiseaseCompletedNCT06889246Not applicable
- Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg Chewable Tablets and Riopan 800 mg Chewable Tablets in Healthy VolunteersCompletedNCT06552624Not applicable
- Effectiveness of a Butyrate Formulation and Butyrate + Polyphenol Formulation on Gut Health, Permeability and Associated SymptomsCompletedNCT06419231Not applicable
- A First-in-Human Study to Learn How Well a Bi-Layer Calcium Carbonate Antacid Tablet Works Compared to a Standard, Non-Layered Calcium Carbonate Tablet in Healthy Male ParticipantsCompletedNCT06293326Phase 1
- Smartphone App-assisted PPICompletedNCT06094062Not applicable
- The Effect of the LEFT Smartwatch App as Sleep Positional Therapy for Nocturnal Gastroesophageal Reflux Symptoms.CompletedNCT06075082Not applicable
- Primary carE PPi dEprescRibing TrialActive, not recruitingNCT05629143Phase 4
- Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERDCompletedNCT05556824Phase 2
- Study to Evaluate the Efficacy of Poppi Apple Cider Vinegar Prebiotic Soda to Improve Gut Health In ParticipantsCompletedNCT05418439Not applicable
- Tolerability Study of Panosyl-Isomaltooligosaccharides (PIMO) and a Placebo in Subjects With HeartburnCompletedNCT05363618Not applicable
- Implementation of a Minor Ailment Service in Community Pharmacy PracticeCompletedNCT05247333Not applicable
- Protocol for the ESREFLUJO Study: Epidemiological Study of Heartburn and Gastroesophageal Reflux in Community PharmacyStatus unknownNCT05162079
- Bile Reflux Gastropathy: Prevalence and Risk Factors After Therapeutic Biliary InterventionsCompletedNCT05131802
- Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2Status unknownNCT04846010Phase 1/2
- Efficacy of Vitamin C Supplement vs Spinal Manipulation to Treatment in Lateral EpicondylitisStatus unknownNCT04445727Not applicable
- A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and CirrhosisStatus unknownNCT04301908
- Study of Dietary Patterns and Food Diversity in Russian GERD PatientsStatus unknownNCT04252144Not applicable
- An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) TherapyStatus unknownNCT04157257Phase 2
- Upset Stomach Relief for Mild and Moderate Indigestion and HeartburnCompletedNCT04153552Not applicable
- Effectiveness of Diaphragmatic Breathing on Reflux Symptoms in OutpatientsCompletedNCT04120025Not applicable
- Effects of Mucosave® on Gastrointestinal DiscomfortCompletedNCT04119817Not applicable
- Fermented Soy and Heartburn Symptom ReliefCompletedNCT03867591Not applicable
- Folic Acid in Pediatric Inflammatory Bowel DiseaseStatus unknownNCT03860012Phase 4
- Mipolixin® Compared to Poliprotect® in Moderate Functional Dyspepsia and Heartburn.CompletedNCT03531372Not applicable
- Efficacy of Zinc L-carnosine in Maintaining Remission of Gastroesophageal Reflux DiseaseStatus unknownNCT03467438Phase 4
- Radiofrequency Energy Delivery for Gastroesophageal Reflux DiseaseStatus unknownNCT03223116Not applicable
- Registry of Outcomes From AntiReflux SurgeryCompletedNCT02923362
- Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral ResectionCompletedNCT02852564Phase 1
- Image-Enhanced Endoscopy (IEE) for Diagnosis of Non-Erosive Reflux DiseaseCompletedNCT02629081
- Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in PregnancyCompletedNCT02470117Phase 4
- The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of ChildrenStatus unknownNCT02301650
- Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep DisturbancesStatus unknownNCT02277886Phase 4
- Questionnaire to Assess Gastrointestinal Symptoms of Oral Iron.CompletedNCT02146053Early Phase 1
- Research of Efficient Use of Omeprazole in Combination With Domperidone in Gastroesophageal Reflux Disease of Mild to Moderate SeverityStatus unknownNCT02140073Phase 4
- Efficacy Study of Articaine Lozenge to Enhance the Procedural Compliance of the Adults Undergoing GastroduodenoscopyStatus unknownNCT02105090Phase 4
- Placebo Controlled Phase IV Study to Compare the Efficacy and Safety of a Single Dose of Oral Talcid, a Single Dose of Oral Famotidine and a Single Dose of Placebo in Patients With Acute Heartburn EpisodesCompletedNCT01928888Phase 4
- The Role of HIF-2a in the Pathogenesis of Reflux EsophagitisCompletedNCT01733810Not applicable
- Safety and Efficacy of IQP-LH-101 in Postprandial HeartburnCompletedNCT01718639Phase 4
- Domperidone in Treating Patients With Gastrointestinal DisordersActive, not recruitingNCT01696734Phase 3
- Decision Aid for Gastroesophageal Reflux Disease ManagementStatus unknownNCT01641887
- Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.CompletedNCT01601379
- Hearing Preservation Using Dexamethasone and Hyaluronic Acid for Cochlear ImplantationCompletedNCT01588925Phase 2
- Efficacy Study of AGSPT201 Tablet to Treat Gastroesophageal Reflux DiseaseCompletedNCT01400945Phase 3
- Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux DiseaseCompletedNCT01338077Phase 3
- A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)CompletedNCT01337804Phase 1